Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia
Top Cited Papers
- 1 June 2004
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 190 (6) , 1541-1547
- https://doi.org/10.1016/j.ajog.2004.03.043
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The biology of VEGF and its receptorsNature Medicine, 2003
- Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces ProteinuriaJournal of Biological Chemistry, 2003
- Recent Insights into the Pathogenesis of Pre-eclampsiaPlacenta, 2002
- Vascular Endothelial Growth Factor Ligands and Receptors That Regulate Human Cytotrophoblast Survival Are Dysregulated in Severe Preeclampsia and Hemolysis, Elevated Liver Enzymes, and Low Platelets SyndromeThe American Journal of Pathology, 2002
- VEGF165 mediates glomerular endothelial repairJournal of Clinical Investigation, 1999
- Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction PathwayJournal of Biological Chemistry, 1998
- Risk factors associated with preeclampsia in healthy nulliparous womenPublished by Elsevier ,1997
- Differential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor GenesJournal of Biological Chemistry, 1997
- Placental Cytokines and the Pathogenesis of PreeclampsiaAmerican Journal of Reproductive Immunology, 1997
- Colocalisation of Vascular Endothelial Growth Factor and Its Flt-1 Receptor in Human PlacentaGrowth Factors, 1995